Drug
Bmab 1000
Bmab 1000: highest development phase Phase 3, developed by Biocon. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Biocon
Trials
| Drug | Phase | Indication |
|---|---|---|
| Bmab 1000 NCT05345691 | Phase 3 | Postmenopausal Women With Osteoporosis |
| Bmab 1000 NCT05323708 | Phase 1 | Healthy Volunteers |
Latest
No recent events.
Follow Bmab 1000 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.